Fifty410 vs GobyMeds: Starter and High-Dose GLP-1 Costs Compared

Last reviewed: September 6, 2026 Last updated: September 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Fifty410 and GobyMeds both offer compounded GLP-1 injections with all-in pricing, but they structure payments differently. Fifty410 charges $199/month for semaglutide (billed monthly) and $399–$549 upfront for tirzepatide in 3-month bundles that ship upfront and tier by dose. GobyMeds charges $299–$499 upfront for semaglutide in 3-month bundles that tier by dose, and $299/month for tirzepatide billed monthly at any dose. Over 12 months Fifty410's high-dose tirzepatide costs $2,196 total ($183/month average, prepaid); GobyMeds' month-to-month tirzepatide costs $3,588 total ($299/month). For semaglutide, GobyMeds' low-tier bundle costs $1,196 over 12 months ($99.67/month average, prepaid in quarterly chunks); Fifty410's monthly semaglutide costs $2,388 ($199/month). The right choice depends on whether you want to pay upfront in bundles or prefer monthly billing, and whether your dose is predictable.

At-a-glance comparison

All figures verified September 4, 2026. Prepaid per-month calculations are ours and labeled below.

Normalized 12-month costs

Fifty410 and GobyMeds each use prepaid bundles for one compound but not the other. To see true recurring cost we calculate the annual total assuming quarterly renewal where bundles apply, then convert back to a monthly average. All figures below are our calculation from the advertised bundle or monthly rates.

Semaglutide over 12 months

• Fifty410: $199/month × 12 = $2,388 total ($199/month, billed monthly).
• GobyMeds low tier (0.2–0.4 mg): $299 upfront per quarter × 4 = $1,196 total ($99.67/month average, prepaid quarterly).
• GobyMeds mid tier (up to 1.5 mg): $399 upfront per quarter × 4 = $1,596 total ($133/month average, prepaid quarterly).
• GobyMeds high tier (up to 2.3 mg): $499 upfront per quarter × 4 = $1,996 total ($166.33/month average, prepaid quarterly).
• PlexusDx month-to-month: $189/month × 12 = $2,268 total ($189/month, same price at every dose).

GobyMeds' semaglutide bundles are the lowest-cost option if you stay in the low tier. Every dose increase triggers a tier jump and a higher quarterly payment. Fifty410's semaglutide is month-to-month and does not tier by dose, so your monthly bill stays $199 whether you're at 0.25 mg or 2.4 mg. PlexusDx sits between Fifty410 and GobyMeds' mid tier on a month-to-month basis, with no dose tiers.

Tirzepatide over 12 months

• Fifty410 starter dose: $399 upfront per quarter × 4 = $1,596 total ($133/month average, prepaid quarterly).
• Fifty410 mid dose: $499 upfront per quarter × 4 = $1,996 total ($166.33/month average, prepaid quarterly).
• Fifty410 high dose: $549 upfront per quarter × 4 = $2,196 total ($183/month average, prepaid quarterly).
• GobyMeds month-to-month (any dose): $299/month × 12 = $3,588 total ($299/month).
• GobyMeds starter bundle: $399 upfront per quarter × 4 = $1,596 total ($133/month average, prepaid quarterly, starter dosing only).
• PlexusDx month-to-month: $289/month × 12 = $3,468 total ($289/month, same price at every dose).

Fifty410's tirzepatide bundles deliver the lowest 12-month cost if you can commit to quarterly prepay and know which tier you'll stay in. GobyMeds' tirzepatide is month-to-month but costs $299 per month at any dose—$120 more per year than PlexusDx and $1,392 more than Fifty410's high-dose bundle. GobyMeds does offer a starter bundle at $399 upfront, matching Fifty410's starter tier, but that applies only to initial dosing.

Decision factors

Payment timing and flexibility

Fifty410 requires $399–$549 upfront for tirzepatide and ships the full 3-month supply immediately. GobyMeds requires $299–$499 upfront for semaglutide and ships that bundle upfront. If a quarterly prepayment is difficult or you want the option to pause or adjust without forfeiting unshipped medication, month-to-month billing (Fifty410 semaglutide, GobyMeds tirzepatide, or PlexusDx either compound) offers more control. If you have the cash flow and want the lowest per-month calculation, the prepaid bundles win.

Dose predictability

Both competitors tier their prepaid bundles by dose. If your provider increases your dose mid-bundle you will move to a higher tier at the next renewal, raising your quarterly payment. Fifty410's tirzepatide tiers span starter (typically 2.5–5 mg), mid (7.5–10 mg), and high (12.5–15 mg). GobyMeds' semaglutide tiers span 0.2–0.4 mg (low), up to 1.5 mg (mid), and up to 2.3 mg (high). If you're titrating and expect dose changes, flat-rate month-to-month plans (PlexusDx or the non-bundled compound at each competitor) eliminate surprise tier jumps.

Upfront commitment and shipped inventory

Fifty410 ships tirzepatide bundles upfront; GobyMeds ships semaglutide bundles upfront. You receive the full 12-week supply immediately, which simplifies logistics but also means you own that inventory. If you need to stop therapy or switch compounds, unused medication typically cannot be returned or refunded. Month-to-month plans ship 4 weeks at a time, reducing financial exposure if circumstances change.

Service quality and reviews

Fifty410 reports a 4.8-star rating on Trustpilot with 5,891 reviews (captured from the provider's website, September 4, 2026). We did not capture GobyMeds' current Trustpilot rating or volume; a profile exists but no rating data was indexed in this evidence pass. PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). Review ratings offer one signal of service consistency; confirm current ratings and read recent feedback on Trustpilot directly before deciding.

Choose Fifty410 if…

• You want month-to-month semaglutide with no tier surprises and can accept a $199/month rate that sits above PlexusDx ($189) but below GobyMeds' unbundled option.
• You can prepay $399–$549 quarterly for tirzepatide and expect to remain in one dose tier, delivering a 12-month cost as low as $1,596 (starter) or $2,196 (high dose).
• You prefer to receive the full 3-month tirzepatide supply upfront rather than monthly shipments.
• The 4.8-star Trustpilot rating (provider-reported, September 2026) gives you confidence in support and fulfillment consistency.

Choose GobyMeds if…

• You want semaglutide at the lowest per-month calculation ($99.67/month average in the low tier, $1,196 over 12 months) and can commit to $299–$499 quarterly prepay.
• Your semaglutide dose is stable and predictable, so tier increases are unlikely.
• You want month-to-month tirzepatide at any dose without prepay, and the $299/month rate ($3,588/year) fits your budget.
• You value overnight shipping (included in GobyMeds' advertised package) and want the flexibility to pause tirzepatide monthly if needed.

Where PlexusDx fits

PlexusDx charges $189/month for semaglutide injection and $289/month for tirzepatide injection, billed monthly with no dose tiers and no prepay required. Over 12 months that totals $2,268 for semaglutide and $3,468 for tirzepatide. PlexusDx sits above GobyMeds' low-tier semaglutide bundle and above Fifty410's tirzepatide bundles, but $10 below Fifty410's month-to-month semaglutide and $10 below GobyMeds' month-to-month tirzepatide. You pay the same price whether you're at a starter dose or maximum dose, and you can choose 3-month or 6-month commit pricing (semaglutide $169 or $149/month, tirzepatide $269 or $249/month) if you want a lower rate without quarterly tier risk. Every plan includes the provider visit, prescription, compounded medication, and shipping in one price, and you can pause or adjust monthly with no forfeited inventory.

Methodology and freshness

Pricing, billing cadence, dose tiers, and inclusions were verified from each provider's checkout flow or pricing page, captured September 4, 2026. Trustpilot ratings and review volumes are as reported on provider websites or captured directly from Trustpilot on that date. Twelve-month totals and per-month averages for prepaid bundles are our calculation, derived by multiplying the advertised quarterly rate by four. We assumed quarterly renewal at the same tier; actual cost will vary if dose increases trigger a tier change. No promotional codes or discounts were applied. Readers should confirm current pricing, shipping terms, dose-tier definitions, and refund policies at checkout before committing.

Frequently Asked Questions

Do Fifty410 and GobyMeds ship the full 3-month supply upfront or monthly?

Fifty410 ships the full 3-month tirzepatide supply upfront when you pay the quarterly bundle. GobyMeds ships the full 3-month semaglutide supply upfront when you pay the quarterly bundle. The non-bundled option at each provider (Fifty410 semaglutide, GobyMeds tirzepatide) ships monthly.

What happens if my dose increases mid-bundle?

If your provider increases your dose and the new dose falls into a higher tier, your next quarterly payment will reflect that higher tier rate. The increase applies at renewal, not mid-bundle. Confirm tier boundaries and dose progression expectations with your provider before committing to a prepaid plan.

Can I switch from semaglutide to tirzepatide or vice versa?

Both providers allow compound switches subject to provider approval, but switching mid-bundle may forfeit unused medication or require a new purchase. Month-to-month plans let you switch at the next billing cycle with less financial exposure. Confirm the switch policy and any restocking or refund terms before enrolling.

Are these compounded medications FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Neither Fifty410, GobyMeds, nor PlexusDx compounded semaglutide or tirzepatide is FDA-approved or interchangeable with brand-name Ozempic, Wegovy, Mounjaro, or Zepbound.

Which provider offers the lowest 12-month cost for high-dose tirzepatide?

Fifty410's high-dose tirzepatide bundle costs $2,196 over 12 months ($549 quarterly, prepaid), the lowest among the three if you remain in the high tier. PlexusDx month-to-month is $3,468 over 12 months, and GobyMeds month-to-month is $3,588. The savings require quarterly prepay and accepting all medication upfront.

Sources

• Fifty410 pricing page and checkout flow (accessed September 4, 2026)
• GobyMeds pricing page and checkout flow (accessed September 4, 2026)
• Fifty410 Trustpilot profile (accessed September 4, 2026)
• GobyMeds Trustpilot profile (accessed September 4, 2026)
• PlexusDx Trustpilot profile (accessed September 4, 2026)
• PlexusDx pricing pages (accessed September 6, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.